As a result, the body is induced by a cascade of immune reactions directed to the destruction and elimination of pathogens and cells infected by them. The cells – producers of interferon acquire the ability to develop enhanced interferon in response to the re-induction, caused by pathological agent. This property is preserved for a long time after discontinuation of the drug. Immunomodulatory effects due to the ability trenbolone acetate buyactivated hematopoietic stem cells, to normalize the balance of subpopulations of T-lymphocytes, stimulate effector parts of the immune system. Has a pronounced stimulating effect on the functional activity of macrophages and polymorphonuclear leucocytes, increasing their migration and phagocytic activity. Corrects tissue growth: Activates NK-cells enhances all forms of cytotoxicity, a positive effect on recovery adhesiveness cells inhibits their proliferative and metastatic activity . Pharmacokinetics: In intramuscular bioavailability is more than 90%. After administration of 100-500 mg maximum plasma concentration is reached after 15-30 minutes and is 8.3 mg / ml. After 5 hours, only minor amounts determined , after 6 hours in plasma not detectable. Excreted unchanged by the kidneys without being metabolized, a half-life of 1 hour. After 15-30 min after administration plasma begin to increase endogenous interferon titers, especially early and interferon. 2 revealed a peak content of interferon in the plasma of 70 IU / ml after 1.5-2 hours and 110 IU / ml at 8-10 hours after which the interferon content and begins to decline. After 24 hours, the concentration of endogenous interferons remains high enough to the original values returned through 46-48 hours after administration.
In a monotherapy or in combination therapy:
– influenza and other acute respiratory viral diseases, including the background of immunodeficiency states;
– infections caused by the virus Herpes simplex, Varicella zoster, Herpes simplex genitalis, including persons with disorders of the immune system
– cytomegalovirus trenbolone acetate buy infection in immunosuppressed persons;
– radiation immunodeficiency;
– HIV infection
– encephalitis and encephalomyelitis virus etiology;
– acute and chronic hepatitis B and C;
– urethritis, epididymitis, prostatitis, cervicitis, and salpingitis chlamydial infection;
– lymphogranuloma venereum;
– multiple sclerosis;
– Candida skin lesions and mucous membranes;
– human papillomavirus infection.
Prophylaxis of influenza and other acute respiratory viral diseases.
Pregnancy and lactation
The safety of Neovir ® during pregnancy and lactation has not been studied, and the drug is contraindicated during pregnancy and lactation.
Hypersensitivity of the drug. Pronounced impairment of renal function (creatinine clearance less than 30 mL / min). Autoimmune disease. Pregnancy and lactation, children under 18 years.
Apply elderly patients.
DOSAGE AND ADMINISTRATION
The solution for injection is administered intramuscularly, single therapeutic dose is 250 mg (1 ampoule) or 4-6 mg per kg of patient body weight. If necessary, a single dose of the preparation can be increased to 500 mg.
The course of treatment, unless otherwise indicated, includes intramuscular injections of 7.5 trenbolone acetate buy 250 mg every 48 hours, course dose depends on the clinical picture. The duration of 8-12 days. Single prophylactic dose is 250 mg (1 ampoule) or 6.4 mg per kg body weight. With prolonged use of the recommended interval between injections 3-7 days.
When HIV for Injection is used in combination with specific antiviral drugs. The treatment course consists of 10 injections of 250 mg every 48 hours between injections. After the course, make a break for 2 months. Perhaps the use of repeated courses indicated.
In rare cases may cause allergic reactions such as skin rash. There are low-grade fever, local pain rapidly passing into the injection site. When poor tolerability or soreness at the injection site is recommended to introduce together with the local anesthetic solution (2 ml 0.25-0.5% procaine solution).
Neovir cases of overdose has not been described.
Interacting ones with other drugs
Physico-chemical incompatibility and other undesirable interactions have been identified.
Information about possible negative impact of the drug on the performance of potentially hazardous activities that require attention and fast reactions (driving and other vehicles, work with moving machinery, the work manager and operator, etc.) is missing.
solution for intramuscular injection 250 mg / 2 ml in lighting glass ampoules of 2 ml; 3, 5 vials in blisters made of PVC film; 1 contour cellular packaging with instruction on the medical application in a pack made of cardboard. shop steroids eminence labs steroidwithdrawal.biz